Tasmar and anaemia Patient Reports February 10, 2010
Tasmar Side Effects Report #5281224-0
Tasmar side effect was reported by a Physician from GERMANY on Mar 06, 2007. Male patient, 80 years of age, was diagnosed with parkinsonism and was treated with Tasmar. After drug was administered, patient experienced the following side effects: anaemia, blood creatine phosphokinase increased, compartment syndrome, deep vein thrombosis
, hepatic enzyme increased, multi-organ failure, myocardial infarction. Tasmar dosage: unknown. During the same period patient was treated with ISOCOM, SIFROL, TRAZODONE, SEROQUEL, AMANTADINE. Patient was hospitalized. Patient died on 01/27/2007.Tasmar Side Effects Report #5291405-8
Tasmar side effect was reported by a Physician from GERMANY on Mar 13, 2007. Male patient, 80 years of age, was diagnosed with parkinsonism and was treated with Tasmar. After drug was administered, patient experienced the following side effects: acute hepatic failure, anaemia, blood creatine phosphokinase increased, cardiovascular disorder, coagulopathy, compartment syndrome, deep vein thrombosis
, factor v leiden mutation, multi-organ failure. Tasmar dosage: unknown. During the same period patient was treated with ISOCOM, SIFROL, TRAZODONE, SEROQUEL. Patient was hospitalized. Patient died on 01/27/2007.Tasmar Side Effects Report #5306612-5
Tasmar side effect was reported by a Physician from GERMANY on Apr 03, 2007. Male patient, 80 years of age, weighting 138.9 lb, was diagnosed with parkinsonism and was treated with Tasmar. After drug was administered, patient experienced the following side effects: anaemia, compartment syndrome, condition aggravated, deep vein thrombosis
, haemorrhage, hepatic failure, international normalised ratio increased, multi-organ failure, myocardial infarction. Tasmar dosage: 100 MG;TID; PO. During the same period patient was treated with ISOCOM, SIFROL, TRAZODONE, SEROQUEL, CARBIDOPA. Patient was hospitalized. Patient died on 01/27/2007.
Tasmar and anaemia 